VEGF level testing is the simplest tool for assessing the process of angiogenesis, but its inhibition is also indirectly expressed by tumour size and metastasis reduction, which was observed in studies where lycopene was used in the treatment of prostate cancer [19,25,97]. This evidence concerns the gene VEGFA and prostate cancer.